Home

Loading...

Table of contents

Microscopic colitis

Guidelines

Key sources

The following summarized guidelines for the evaluation and management of microscopic colitis are prepared by our editorial team based on guidelines from the United European Gastroenterology (UEG/EMCG 2021), the American College of Gastroenterology (ACG 2017), and the American Gastroenterological Association (AGA 2016). ...
Show more

Screening and diagnosis

Differential diagnosis: as per EMCG/UEG 2021 guidelines, rule out microscopic colitis in patients fulfilling the criteria for functional bowel disease, especially in presence of risk factors for microscopic colitis and/or in absence of IBS-therapy response.
B
Create free account

More topics in this section

  • Histological criteria

Classification and risk stratification

Severity assessment: as per EMCG/UEG 2021 guidelines, consider assessing disease activity and clinical remission in patients with microscopic colitis by the Hjortswang criteria, in the absence of a formally validated metric of disease activity. Consider a mean of < 3 stools/day and a mean of < 1 water stool/day during a 1-week registration as a criteria for clinical remission.
C
Hjortswang's criteria for clinical remission of microscopic colitis
Mean of < 3 stools per day
Mean of < 1 watery stool per day
Criteria not met

Diagnostic investigations

Stool studies: as per EMCG/UEG 2021 guidelines, do not obtain fecal calprotectin for exclusion of microscopic colitis or monitoring of patients with microscopic colitis.
D

More topics in this section

  • Testing for celiac disease

  • Testing for bile acid diarrhea

Diagnostic procedures

Colonoscopy: as per EMCG/UEG 2021 guidelines, perform ileocolonoscopy with biopsies from at least the right and left side of the colon in patients with suspected microscopic colitis.
A

Medical management

Budesonide: as per EMCG/UEG 2021 guidelines, administer oral budesonide to induce remission in patients with collagenous
B
and lymphocytic colitis.
B
Show 2 more

More topics in this section

  • Prednisolone

  • Aminosalicylates

  • Other immunosuppressants

  • Bismuth salicylate

  • Antidiarrheal agents

  • Probiotics

  • Antibiotics

Nonpharmacologic interventions

Withdrawal of offending medications: as per EMCG/UEG 2021 guidelines, consider withdrawal of any drugs with a suspected chronological relationship between drug introduction and onset of diarrhea.
C

Surgical interventions

Indications for surgery: as per EMCG/UEG 2021 guidelines, consider surgery in selected patients with microscopic colitis as last option if all medical therapy fails.
C

Preventative measures

Immunizations: as per ACG 2017 guidelines, provide annual vaccination against influenza in all adult patients with IBD. Administer the non-live trivalent inactivated influenza vaccine, and not the live inhaled influenza vaccine, in patients on immunosuppressive therapies and their household contacts.
B
Show 7 more

Follow-up and surveillance

Surveillance colonoscopy: as per EMCG/UEG 2021 guidelines, do not obtain more frequent surveillance colonoscopy for CRC in patients with microscopic colitis, as the disease does not increase the risk of CRC or adenoma.
D

More topics in this section

  • Surveillance biopsy

  • Cervical cancer surveillance